Urofollitropin Completed Phase 4 Trials for Olfacto genital dysplasia / Idiopathic Hypogonadotropic Hypogonadism Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01403532Sequential Therapy for Hypogonadotropic Hypogonadism